Home
Scholarly Works
Rivaroxaban Reduces Major Cardiovascular and Limb...
Journal article

Rivaroxaban Reduces Major Cardiovascular and Limb Events in Patients with CKD and Peripheral Artery Disease with Recent Lower Extremity Revascularization: Insights from VOYAGER PAD

Authors

Hsia J; Nehler MR; Anand S; Patel MR; Hiatt WR; Debus S; Hess C; Capell WH; Diao L; Berkowitz SD

Journal

Journal of the American Society of Nephrology, Vol. 31, No. 10S, pp. 649–649

Publisher

Wolters Kluwer

Publication Date

November 17, 2020

DOI

10.1681/asn.20203110s1649b

ISSN

1046-6673

Contact the Experts team